Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

BRCA1 and BRCA2 Testing Linked to Wide Lifetime Cancer Risk Differences

Lifetime breast and ovarian cancer risk varied sharply by BRCA result and family history in an Ontario cohort of women tested from 2007 to 2016.

A Colombian man’s worsening upper GI symptoms expose how delayed endoscopy and presumptive reflux treatment can postpone gastric…

A JAMA Network Open cohort study found broadly similar survival with Lu-177 PSMA across treatment lines and taxane…

In 461,682 older US adults, total ultra-processed food intake was not tied to colorectal cancer, though meat, dairy,…

Somalia rebuilt cancer pathology capacity after decades of instability, but major gaps remain in advanced diagnostics, staffing, and…

Archō’s oncology advocacy report ranks Eli Lilly first in five categories, while Pfizer places in the top three…

A lengthy study in older adults found no association between ultraprocessed food intake and colorectal cancer, challenging a…

Women treated for breast cancer can enter abrupt menopause with severe symptoms, fertility loss and little warning, as…

A mother is backing new guidance after her daughter died from angiosarcoma, a rare soft tissue sarcoma with…

iOnctura’s roginolisib showed survival, immune, and safety signals in phase 1 metastatic uveal melanoma, with no dose-limiting toxicities.

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds